Preethi Sundaram - 10 Jun 2025 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Issuer symbol
CPRX
Transactions as of
10 Jun 2025
Net transactions value
-$103,649
Form type
4
Filing time
12 Jun 2025, 17:00:42 UTC
Previous filing
19 Feb 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sundaram Preethi Chief Strategy Officer 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES /s/ Preethi Sundaram 12 Jun 2025 0001872422

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common Stock, par value $0.001 per share Sale $61,377 -2,324 -5.2% $26.41 42,681 10 Jun 2025 Direct F1, F2
transaction CPRX Common Stock, par value $0.001 per share Sale $42,272 -1,600 -3.7% $26.42 41,081 11 Jun 2025 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.49 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in a range from $26.39 to $26.48 per share.